Literature DB >> 26513301

Pain in amyotrophic lateral sclerosis: Patient and physician perspectives and practices.

Helen E Stephens1, Erik Lehman2, Divisha Raheja1, Chengwu Yang2,3, Susan Walsh4, Donna B Mcarthur5, Zachary Simmons1,6.   

Abstract

Our objective was to better understand the experience and impact of pain on ALS patients in the U.S., and to survey ALS physicians on their pain assessment and management practices. Individuals with ALS were invited to complete an online survey of pain in ALS. ALS specialist physicians were sent an e-mail survey about their experiences in evaluating and managing patients' pain. Nearly 75% of patients with ALS reported significant pain, and most thought that ALS was the source of at least some of this pain. Pain intensity scores (mean 3.9/10) and pain interference scores (mean 4.3/10) were moderate on average, but nearly 80% of participants were using pain medication, including 22% using opioids. Nearly 25% of patients thought they needed stronger pain medication than they were receiving. Physicians generally assess and manage pain in ALS patients, but few use standardized assessment tools. Nearly two-thirds felt that there is a need for better pain management practices and more than one-third felt better training was needed. In conclusion, pain in patients with ALS is not always well controlled. Improvement in care may be facilitated by a more standardized approach to evaluation, and by additional education and training of ALS health care professionals.

Entities:  

Keywords:  Pain; amyotrophic lateral sclerosis; assessment

Mesh:

Year:  2015        PMID: 26513301     DOI: 10.3109/21678421.2015.1074701

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  5 in total

1.  Pain in amyotrophic lateral sclerosis: a narrative review.

Authors:  Soyoung Kwak
Journal:  J Yeungnam Med Sci       Date:  2022-06-08

2.  Associations of Patient Mood, Modulators of Quality of Life, and Pharmaceuticals with Amyotrophic Lateral Sclerosis Survival Duration.

Authors:  Leila Bond; Gloria Bowen; Benjamin Mertens; Keelie Denson; Kathleen Jordan; Branislav Vidakovic; Cassie S Mitchell
Journal:  Behav Sci (Basel)       Date:  2020-01-10

3.  Pain-Related Factors and Their Impact on Quality of Life in Chinese Patients With Amyotrophic Lateral Sclerosis.

Authors:  Ran An; Yuan Wu; Yi Li; Xin Li; Shaolong Ai; Yanming Xu; Chengqi He
Journal:  Front Neurosci       Date:  2022-07-13       Impact factor: 5.152

4.  Disability and Contextual Factors in Patients with Amyotrophic Lateral Sclerosis - A Three-Year Observational Study.

Authors:  Petter Sandstedt; Susanne Littorin; Sverker Johansson; Kristina Gottberg; Charlotte Ytterberg; Marie Kierkegaard
Journal:  J Neuromuscul Dis       Date:  2018

5.  The Evaluation of Pain with Nociceptive and Neuropathic Characteristics from Three Different Perspectives in Amyotrophic Lateral Sclerosis Patients: A Case Controlled Observational Study in Southwestern China.

Authors:  Ran An; Yan Li; Xianghua He; Cheng Li; Xin Li; Yanming Xu; Chengqi He
Journal:  Neural Plast       Date:  2021-07-30       Impact factor: 3.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.